Drug intelligence / Profile preview

CYP1A1 siRNA

Development stage
Unknown
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

CYP1A1 siRNA is a small interfering RNA designed to target and knock down the expression of cytochrome P450 1A1 (CYP1A1). In preclinical research, it is widely used to investigate the role of CYP1A1 in xenobiotic metabolism, lipid peroxidation, and cancer cell proliferation and survival. Studies have demonstrated that siRNA-mediated knockdown of CYP1A1 can inhibit the proliferation of breast, prostate, and lung cancer cells, promote apoptosis, and attenuate lipid accumulation and oxidative stress. It is primarily utilized as a research-use-only (RUO) laboratory tool.

Other names
CYP1A1 small interfering RNACYP-1A1 small interfering RNACYP 1A1 small interfering RNAcytochrome P450 1A1 siRNA
02

Targets

CYP1A1 (Cytochrome P450 1A1)

Beyond the preview

Go deeper on CYP1A1 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CYP1A1 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call